Company Announcements

AGM Statement

Source: RNS
RNS Number : 9479T
Renold PLC
24 July 2020
 

24 July 2020

Renold plc

("Renold", "the Company" or "the Group")

AGM Statement

Renold, a leading international supplier of industrial chains and related power transmission products, issues the following statement ahead of its Annual General Meeting to be held at 11:00am today. The statement provides an update on the Group's first quarter of the financial year ending 31 March 2021 ('the Quarter').

 

Group performance during the first Quarter has remained in line with the Company's Results Statement issued for the year ended 31 March 2020. Renold has been profitable and cash generative in each month of the first Quarter of the new financial year. Whilst Group order intake has reflected the challenging market conditions, gradual improvements have been seen since April 2020.

 

It is still too early to give specific guidance for the year ahead. However, with the strategic actions and cost saving measures taken to date, the Board is confident that the Company can manage through the current period of disruption. Renold is well positioned to benefit as markets stabilise and demand recovers.

 

 

Robert Purcell, Chief Executive of Renold, said:

 

"Whilst the market environment continues to be challenging, I am pleased that the Group remains profitable and our cash position is healthy.

 

"The strategic programme that has been undertaken over the past years has resulted in a more resilient business that is better placed to overcome today's challenges. We are focused on ensuring Renold can respond strongly as markets recover."

 

Enquiries:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive




Peel Hunt

020 7418 8900

Mike Bell


Ed Allsopp




Instinctif Partners

020 7457 2020

Mark Garraway

07771 860 938

Rosie Driscoll

07891 564 641

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSEIFADESSESW